Results 11 to 20 of about 15,411,498 (232)

Unsatisfactory SurePath liquid‐based Papanicolaou tests [PDF]

Cancer Cytopathology, 2009
AbstractBACKGROUND:The introduction of liquid‐based Papanicolaou (Pap) tests (LBPTs) has reduced the incidence of unsatisfactory Pap tests (UPTs), but little is known about their causes and significance, especially in the case of SurePath LBPTs.METHODS:All unsatisfactory LBPTs from January 1, 2003 to December 31, 2006 were retrieved.
Mariam, Alsharif, Dan M, McKeon, H Evin, Gulbahce, Kay, Savik, Stefan E, Pambuccian   +4 more
openaire   +3 more sources

Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis. [PDF]

Ann Saudi Med, 2016
BACKGROUND The Papanicolaou (Pap) test is one screening strategy used to prevent cervical cancer in developed countries. The p16/Ki-67 immunocytochemistry is a triage test performed on Pap smears in women with atypical squamous cells of undetermined ...
Chen CC, Huang LW, Bai CH, Lee CC.
europepmc   +2 more sources

Factors related to non-adherence to the realization of the Papanicolaou test

, 2015
Objective: to identify reasons for low adherence to the Papanicolaou test in women seeking care in primary health care. Methods: cross-sectional study.
A. Silva, É. Teixeira, Rosângela Aparecida Pimenta Ferrari, Mária, Elisabete Cestari, Alexandrina Aparecida Maciel Cardelli   +5 more
semanticscholar   +3 more sources

Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution [PDF]

Journal of Pathology and Translational Medicine, 2020
Background The decrease in incidence of cervical dysplasia and carcinoma has not been as dramatic as expected with the development of improved research tools and test methods.
Myunghee Kang, Seung Yeon Ha, Hyun Yee Cho, Dong Hae Chung, Na Rae Kim, Jungsuk An, Sangho Lee, Jae Yeon Seok, Juhyeon Jeong   +8 more
doaj   +2 more sources

Time trend analysis and impacts of the COVID-19 pandemic on mammography and Papanicolaou test coverage in Brazilian state capitals [PDF]

BMC Women's Health
Background Breast and cervical cancer are major public health issues globally. The reduction in incidence and mortality rates of these cancers is linked to effective prevention, early detection, and appropriate treatment measures.
Alanna Gomes da Silva, Thales Philipe Rodrigues da Silva, Nádia Machado de Vasconcelos, Filipe Malta dos Santos, Greice de Campos Oliveira, Deborah Carvalho Malta   +5 more
doaj   +2 more sources

Women with Cervical Cancer: Perceptions about the Papanicolaou Test

Aquichan, 2015
Objetivo: examinar las percepciones acerca de la prueba de Papanicolaou (Pap) desde la perspectiva de las mujeres chilenas con cáncer cervical. Diseño: un estudio descriptivo, transversal realizado en Santiago, Chile.
Maria-Teresa Urrutia, Lauren Poupin
doaj   +4 more sources

Cokeromyces recurvatus in a Papanicolaou test: An exceedingly rare finding that can be mistaken for Paracoccidioides brasiliensis. [PDF]

Cytojournal, 2018
Sharma N, Schwartzman JD, Gutmann EJ, Marotti JD, Liu X.   +4 more
europepmc   +2 more sources

Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States. [PDF]

Sex Transm Dis, 2018
Smith JS, Des Marais AC, Deal AM, Richman AR, Perez-Heydrich C, Yen-Lieberman B, Barclay L, Belinson J, Rinas A, Brewer NT.   +9 more
europepmc   +2 more sources

Factors associated with mammogram and Papanicolaou testing among Mexican American older women. [PDF]

Womens Health (Lond)
Rowlinson E, Snih SA.
europepmc   +2 more sources

Association of Speculum Lubrication with Pain and Papanicolaou Test Accuracy [PDF]

Journal of the American Board of Family Medicine, 2012
D. Uygur, T. Guler, E. Yayci, T. Ataçağ, C. Çomunoğlu, G. Kuzey   +5 more
semanticscholar   +2 more sources